Filing Details
- Accession Number:
- 0001021561-11-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-05 18:20:16
- Reporting Period:
- 2011-05-04
- Filing Date:
- 2011-05-05
- Accepted Time:
- 2011-05-05 18:20:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1021561 | Nu Skin Enterprises Inc | NUS | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 870565309 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1329687 | Patricia Negron | C/O Nu Skin Enterprises, Inc. 75 West Center Street Provo UT 84601 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2011-05-04 | 10,000 | $17.04 | 18,650 | No | 4 | M | Direct | |
Class A Common Stock | Acquisiton | 2011-05-04 | 5,000 | $17.76 | 23,650 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2011-05-04 | 15,000 | $34.00 | 8,650 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2011-05-04 | 10,000 | $0.00 | 10,000 | $17.04 |
Class A Common Stock | Stock Option (right to buy) | Disposition | 2011-05-04 | 5,000 | $0.00 | 5,000 | $17.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-05-25 | No | 4 | M | Direct | |
0 | 2017-05-14 | No | 4 | M | Direct |
Footnotes
- Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
- Currently exercisable in full.